Richard Peters
Director · Aprea Therapeutics, Inc.
- 2025
- Jun 17, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard Peters files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John P. Hamill - $30K in APRE purchases and sales in the last 12 months
- Oren Gilad - $25K in APRE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard Peters?
Richard Peters is a corporate insider, tracked as Director of Aprea Therapeutics, Inc. (APRE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Richard Peters last file a Form 4?
The most recent primary Form 4 on record is dated 17 June 2026, one of 3 filings going back to 2025.
Has Richard Peters been buying or selling stock?
Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales across all tracked filings.
